Factors Influencing Readmission Rates of Acute Traumatic Subdural Hematoma in the Elderly

Traumatic Subdural Hematoma Clinical Trial

Official title:

A Retrospective Analysis of Factors Influencing Readmission Rates of Acute Traumatic Subdural Hematoma in the Elderly

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03878043
• Other study ID #: GRMC 160013
• Status: Completed
• Start date: January 2014
• Est. completion date: March 2019

Study information

• Verified date: March 2019
• Source: Genesys Regional Medical Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Acute traumatic subdural hematomas (TSDH) readmission rate is high (27.8%) with an increase in morbidity and cost for the elderly. This study identifies risk factors affecting readmission rates for these patients and presents strategies to reduce it.

Description:

A retrospective analysis was conducted on patients with traumatic brain injuries (ICD-9-CM codes 800.20 - 801.86, 852.00 - 853.05) admitted between 2014 and 2016 at Genesys Regional Medical Center through the trauma service. From this group, the investigators selected patients admitted with traumatic SDH, and those patients were followed over the following 6 months as regards to readmission status. Patients who were readmitted versus patients who were not readmitted were compared. The risk of readmission within 6 months of discharge for SDH was analyzed adjusting for age, prior anticoagulation use, Injury Severity Score (ISS), Glasgow Coma Scale (GCS), gender, time to readmission and co-morbid conditions which included diabetes mellitus, cardiovascular disease, renal disease, chronic obstructive pulmonary disease, and osteoporotic/orthopedic fractures using Cox Proportional Hazards Regression analysis.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 167
• Est. completion date: March 2019
• Est. primary completion date: December 2016
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 105 Years

Eligibility

Inclusion Criteria:

• Patients diagnosed with Traumatic Subdural Hematoma during time of study

Exclusion Criteria:

• Patients who expired.

Related Conditions & MeSH terms

• Hematoma
• Hematoma, Subdural, Intracranial
• Traumatic Subdural Hematoma

Intervention

Other:
• Follow-up Care
Follow up care provided upon readmission to patients who were diagnosed with a TSDH upon initial visit.

Locations

Country	Name	City	State
United States	Genesys Regional Medical Center	Grand Blanc	Michigan

Sponsors (1)

Lead Sponsor	Collaborator
Tarik Wasfie, MD

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of participants readmitted to the hospital	Number of patients diagnosed with TSDH who were readmitted to the hospital within a 6 month time frame	6 months